BCR and B-cell chronic lymphocytic leukemia: In NOD/SCID/γchain (NGS) mouse xenograft model, Herman et al. [25] recapitulated ibrutinib-mediated inhibition of BCR and NF-κB signaling, attenuation of CLL proliferation and survival, and reduction of tumor burden in vivo [25].